Magnetic resonance imaging (MRI) contrast agents are essential for modern medical imaging, but existing MRI contrast agents have limitations that result in poor resolution and ineffective long-term monitoring. Here, the authors report the development of a T1-MRI contrast agent based on a variant of lanmodulin, LanND-Gd, with efficient renal clearance, high relaxivity, and prolonged renal retention compared with commercially available contrast agents.
- Yuxia Liu
- Duyang Gao
- Xiaogang Liu